Trialect

Active

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required)

National Institutes of Health

The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction.
The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.

This Parent Notice of Funding Opportunity is for basic science experimental studies involving humans, referred to in NIH Grants Policy Statement Section 4.1.3.1 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this NOFO include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Studies conducted with specific applications toward processes or products in mind should submit under the appropriate Clinical Trials Required or Clinical Trial Optional NOFO.

Deadlines:

Application Due Date(s): January 26, 2024; May 29, 2024; Sep 26, 2024; Jan 28, 2025; May 28, 2025; Sep 26, 2025; Jan 27, 2026; May 27, 2026; Sep 28, 2026
AIDS Application Due Date(s): April 26, 2024; Aug 26, 2024; Dec 28, 2024; April 26, 2026; Aug 26, 2025; Dec 28, 2025; April 26, 2026; Aug 26, 2026; Dec 28, 2026

PAR-24-076 Expiration Date December 29, 2026

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

PD/PIs must be designated Early Stage Investigators (ESI) by NIH as defined in NOT-OD-17-101 . For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide. Please note that for multiple PD/PIs applications, all PD/PIs must be ESIs and the proposed project must represent a change in direction for each PD/PI.